Member Info for ThePunter1

50 million kits expected to cost £10. Thats just first orders from the UK government, lads we are going to need a bigger factory!

"There is currently no evidence that people who have recovered from Covid-19 and have antibodies are protected from a second infection"

Nor is there evidence to suggest that people with antibodies are not protected. Ultimately the only way to gather enough evidence to decide either way is antibody testing in a huge scale, so that we can determine if those with antibodies get infected again.

There are loads of articles like this dotted around the internet and they are all "maybe", "may","possibly","might". the only way to turn these suggestions into answers is a lot of testing.

Might I suggest using a search engine. Google is very popular these days, back in the day people often used Lycos, Altavista and Yahoo but they are not as popular. What you do is pick a search engine and type the company name in there. It will show you both their official webpages and various press releases about the company. Reading such pages should be a minimum before you consider investing.

"So what is ODX's involvement in that ?"

Maybe try reading the RNS list, geez do people really need spoon feeding this badly?

Only 2 days ago you said this:

"AVCT still is way way behind that and no guarantee of any approval by UK govt or FDA.
Infact, ODX is better placed as they are working closely with the govt."

Stop jumping in and out of shares. There is money to be made by simply holding and not reading too much into who is ahead of who. The potential customerbase is massive.

I have held for several weeks but had to pick up on this. ODX have a signed contract with Mologic to provide manufacturing capability for Mologic's COVID-19 first generation ELISA1 diagnostics test. This new production facility has nothing to do with ODX from what I can see, however remember this from April 20th.

"Mologic has now submitted its test to Public Health England and NHS Scotland for formal validation. Once validated, Omega and Mologic will enter into a longer-term supply agreement with Omega manufacturing up to 46,000 COVID-19 tests per day."

Would they be building a new manufacturing faclity if they had concerns about getting PHE validation?

So the faclility itself is not relevant to ODX, but it does seem to suggets that they are confident on validation. On that basis we could be closer to implementing the deal within ODX recent agreement with Mologic.